PT-141, also known as Bremelanotide, is a synthetic
peptide derived from Melanotan II, originally
developed to stimulate melanin production.
However, during early studies, researchers noticed a
powerful secondary effect�increased sexual
arousal. PT-141 was isolated to focus exclusively on
these effects, without impacting skin pigmentation.
It is now FDA-approved for hypoactive sexual desire
disorder (HSDD) in premenopausal women and is
widely used off-label for men as a libido-enhancing
and erectile support compound.
Unlike PDE5 inhibitors like Viagra or Cialis, PT-141
acts on the brain, not the vascular system, making it
a fundamentally different type of sexual health
therapy.

PT-141

$180.00

Excluding Sales Tax |

Quantity

PT-141, also known as Bremelanotide, is a synthetic peptide derived from Melanotan II, originally developed to stimulate melanin production. However, during early studies, researchers noticed a powerful secondary effect�increased sexual arousal. PT-141 was isolated to focus exclusively on these effects, without impacting skin pigmentation. It is now FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women and is widely used off-label for men as a libido-enhancing and erectile support compound. Unlike PDE5 inhibitors like Viagra or Cialis, PT-141 acts on the brain, not the vascular system, making it a fundamentally different type of sexual health therapy.
PT-141 is used for both therapeutic and enhancement purposes. Benefits include: � Increased libido and sexual desire in men and women � Improved erectile function not reliant on blood flow mechanics � Heightened arousal and sensitivity during intimacy � Effective in cases of sexual dysfunction not responsive to Viagra or Cialis � No impact on blood pressure, making it safer for some cardiac patients � Synergistic with PDE5 inhibitors, when desired Effects are typically felt within 30�60 minutes, peaking around 3 hours and lasting up to 12 hours. Some users report next-day mood and connection benefits, attributed to oxytocin and dopamine interaction.
PT-141 binds to melanocortin receptors, specifically MC3R and MC4R in the central nervous system�receptors deeply involved in regulating sexual behavior, arousal, and reward processing. These receptors are concentrated in the hypothalamus, the region of the brain responsible for instinctive and hormonal drives. Once bound, PT-141 enhances sexual desire by increasing dopamine release and activating neural circuits tied to arousal, motivation, and pleasure. In men, this can lead to spontaneous erections�even in the absence of visual or physical stimulation. In women, it boosts desire, sensitivity, and overall sexual satisfaction. Because it acts centrally rather than peripherally, it works even in individuals with psychological or neurochemical barriers to sexual function.
PT-141 is generally well tolerated, though side effects can include facial flushing, headache, nausea, and increased blood pressure in some users. These are usually dose-dependent and mild. Nasal spray versions tend to have more systemic side effects compared to subcutaneous injection. It is not recommended for individuals with uncontrolled hypertension, heart disease, or those taking dopamine agonists without clinician oversight. Cyclical or event-based use is typically recommended to avoid receptor fatigue.

PT-141

Clinical Overview

Benefits

Mechanism of Action

Safety Considerations

Dosing

Monarch Aesthetics